作者: Masayuki Hashiguchi , Keiko Ohno , Rieko Nakazawa , Satoshi Kishino , Mayumi Mochizuki
DOI: 10.1023/B:CARD.0000033642.49162.04
关键词:
摘要: Purpose: To compare the oral antiplatelets, phosphodiesterase III inhibitor cilostazol and thienopyridine ticlopidine, for one-month effectiveness safety as an adjunctive therapy after coronary stenting.